ID: ALA4588672

Max Phase: Preclinical

Molecular Formula: C17H12FN3O3

Molecular Weight: 325.30

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COc1cc(C#N)ccc1OCc1nnc(-c2ccc(F)cc2)o1

Standard InChI:  InChI=1S/C17H12FN3O3/c1-22-15-8-11(9-19)2-7-14(15)23-10-16-20-21-17(24-16)12-3-5-13(18)6-4-12/h2-8H,10H2,1H3

Standard InChI Key:  ZGKWXFKPLDGQRV-UHFFFAOYSA-N

Associated Targets(Human)

MDA-MB-453 (1139 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF-10A (2462 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DNMT1 Tclin DNA (cytosine-5)-methyltransferase 1 (978 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DNMT3B Tchem DNA (cytosine-5)-methyltransferase 3B (150 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 325.30Molecular Weight (Monoisotopic): 325.0863AlogP: 3.33#Rotatable Bonds: 5
Polar Surface Area: 81.17Molecular Species: NEUTRALHBA: 6HBD: 0
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 2.46CX LogD: 2.46
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.72Np Likeness Score: -1.95

References

1. Lakshmithendral K, Saravanan K, Elancheran R, Archana K, Manikandan N, Arjun HA, Ramanathan M, Lokanath NK, Kabilan S..  (2019)  Design, synthesis and biological evaluation of 2-(phenoxymethyl)-5-phenyl-1,3,4-oxadiazole derivatives as anti-breast cancer agents.,  168  [PMID:30798049] [10.1016/j.ejmech.2019.02.033]

Source